Trump Just Signed s.1582 Into Law - Now the Countdown Begins...

A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on December 18. Investors who make the right moves before then could make up to 40X by 2032...

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields

Avi Kapoor
March 01, 2024

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy .

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.

Amgen Inc. (NASDAQ:AMGN)

  • Dividend Yield: 3.29%
  • Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and cut the price target from $281 to $278 on Feb. 7, 2024. This analyst has an accuracy rate of 67%.
  • RBC Capital analyst Gregory Renza maintained an Outperform rating and raised the price target from $303 to $329 on Feb. 7, 2024. This analyst has an accuracy rate of 72%.
  • Recent News: On Feb. 26, Amgen announced the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.

Medtronic plc (NYSE:MDT)

  • Dividend Yield: 3.31%
  • Oppenheimer analyst Steven Lichtman maintained a Perform rating and raised the price target from $89 to $92 on Feb. 21, 2024. This analyst has an accuracy rate of 73%.
  • Truist Securities analyst Richard Newitter maintained a Hold rating and boosted the price target from $87 to $90 on Feb. 21, 2024. This analyst has an accuracy rate of 73%.
  • Recent News: On Feb. 29, Medtronic filed ITC action against Axonics to stop unauthorized use of Medtronic innovations.

AbbVie Inc. (NYSE:ABBV)

  • Dividend Yield: 3.52%
  • Truist Securities analyst Robyn Karnauskas maintained a Buy rating and raised the price target from $180 to $195 on Feb. 6, 2024. This analyst has an accuracy rate of 66%.
  • HSBC analyst Rajesh Kumar downgraded the stock from Buy to Hold and slashed the price target from $167 to $156 on Dec. 18, 2023. This analyst has an accuracy rate of 68%.
  • Recent News: On Feb. 28, AbbVie and OSE Immunotherapeutics entered into strategic partnership to develop a novel monoclonal antibody for the treatment of chronic inflammation.

 

Read More: Dell, SoundHound AI And 3 Stocks To Watch Heading Into Friday

Continue Reading...

Popular

AP Lifestyles Digest for week of Dec. 1

Here is the AP Lifestyles Digest for the week of Dec. 1. Note AP's Holiday Gift Guide Digest moved Nov. 12 and is included at the end.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Trump Threatens Air Traffic Controllers Amid Shutdown Chaos; Pete Buttigieg Says He 'Wouldn't Last Five Minutes' in Their Job

President Donald Trump has demanded that all air traffic controllers return to work as the nation's aviation system endured another wave of mass flight cancellations, caused by staffing shortages due to the prolonged government shutdown.

Velo3D Stock Soars After Q3 Earnings: Highlights From The Report

Shares of Velo3D, Inc. (NASDAQ:VELO) are rising Tuesday after the metal 3D printing company reported third-quarter earnings results.

Urgent Copper Stock With Strong Catalysts - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad

AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.

Noem Says National Guard Shooting Suspect Was Radicalized In US

DHS Secretary Kristi Noem says that the suspect in the fatal shooting of a National Guard member in Washington was radicalized domestically.

Trump commutes prison sentence for former private equity executive David Gentile

HALLANDALE BEACH, Fla. (AP) — President has commuted the prison sentence of former investment manager David Gentile, who was convicted of defrauding investors — the latest in a Trump has taken in .

The Smart Money Copper Trade - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

Cathie Wood Dumps $11.6 Million Worth Of Tesla Stock: Here Is What Ark Purchased Instead

On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Tesla Inc. (NASDAQ:TSLA), Coinbase Global Inc.

Weiss Gold Veteran Makes Shocking New Call - Ad

Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.

How Tyson's Chicken Business Will Offset Beef Weakness

Tyson shares rise as pricing catch-up expected to ease cost pressures; chicken strength offsets beef headwinds amid stable feed costs.

Trump attacks ABC News correspondent Mary Bruce in angry response to three sharp questions

NEW YORK (AP) — President Donald Trump denounced ABC News' Mary Bruce as a “terrible reporter” Tuesday and threatened the network's license to broadcast after she asked him three sharp questions at the White House.

$270,000 Drug. One Competitor. Billion-Dollar Market. - Ad

Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.

A lost generation of news consumers? Survey shows how teenagers dislike the news media

NEW YORK (AP) — Cat Murphy, a college student, has wanted to be a journalist since she was 11. Many of her friends don't understand why.

These are the 37 donors helping pay for Trump's $300 million White House ballroom

WASHINGTON (AP) — President Donald Trump says his $300 million White House ballroom will be paid for “100% by me and some friends of mine.”

Copper, Silver, Gold, Tungsten - This Nevada Play Offers Multiple Shots on Goal - Ad

Most early-stage resource opportunities rely on one metal. This one doesn't. The Walker Lane belt hosts copper, silver, gold, and tungsten - and recent results across the district confirm all four. This startup has stepped in with multi-metal exposure, giving investors several potential ways to capture upside.

XRP Jumps 10% In A Week As First-Ever Spot ETF Eyes Thursday Launch

XRP (CRYPTO: XRP) surged 10% over the past seven days amid mounting anticipation for the first-ever XRP ETF, which could launch as early as this week.

A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact

BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robust procedure trends.

First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad

This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.

Weekend Round-Up: Airbus Chaos, BYD's Massive Recall, Tesla's Free FSD Rides, Rivian's Tax Credit Silver Lining And More

From emergency aircraft recalls to massive vehicle recalls in China, to free self-driving rides in Europe, the past week was buzzing in the auto and tech sector.

OpenAI's Partners Rake Up $96 Billion Debt as AI Industry's Borrowing Trend Escalates

Companies supplying data centers, chips, and processing power to OpenAI have racked up a staggering $96 billion in debt to fund their operations.

Trump Just Signed s.1582 Into Law - Now the Countdown Begins... - Ad

A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on December 18. Investors who make the right moves before then could make up to 40X by 2032...

Trump Bars South Africa From 2026 G20 Summit In Florida, Freezes Aid Over 'White Genocide'

President Donald Trump directed that South Africa will not be invited to the 2026 G20 Summit in Miami, Florida. He also declared that all U.S. payments and subsidies to the country would be immediately suspended.

Elon Musk Says SpaceX Will Carry '99% Of All Earth Payload' Once Starship Flies Daily

Elon Musk says SpaceX will handle nearly all of Earth's orbital payloads in the coming years as Starship development continues.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Gen Z Takes To 'Income Stacking' As One Pay Check Falls Short

Gen Zers are turning to income stacking to secure their financial future as they fear a single paycheck won't be enough. AI and broken social contract fuel the shift. Side hustles becoming core of young careers.

Urgent Copper Stock With Strong Catalysts - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

(Micro)Strategy's Structural Reset: Why Markets Are Repricing MSTR Beyond Bitcoin

The recent decline in Strategy's (NASDAQ:MSTR) stock price is not a simple pullback, nor is it a reaction driven by short-term sentiment. What is unfolding around MSTR is a broad structural repricing.

US Senate Discloses Landmark Crypto Market Structure Bill, Eyes Passage By Late 2025

Bitcoin (CRYPTO: BTC) is holding steady near $105,000 as markets digest the Senate's long-awaited crypto market structure bill draft, a major milestone toward regulatory clarity

Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad

AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.

Jim Cramer Notes 'Horrible' Bitcoin Start To December As BTC Falls By $4,000 In Minutes

Bitcoin (CRYPTO: BTC) is down almost 6% in the past 24 hours after a sudden wave of long-position liquidations erased nearly $4,000 from price in a

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service